Tags

Type your tag names separated by a space and hit enter

Rectus femoris myotendinous lesion treated with PRP: a case report.
Acta Biomed. 2019 12 05; 90(12-S):178-183.AB

Abstract

BACKGROUND AND AIM OF WORK

Musculoskeletal injuries are the most common cause of severe, chronic pain and physical disability for the majority of all sport-related injuries. Platelet-rich plasma is being used more frequently to promote healing of muscle injuries. We report a case of 39 years old non professional soccer player who came to our attention for a quadriceps muscle pain onset after kicking the ball during a match.

METHODS

Clinical and instrumental evaluation revealed a myotendinous junction rupture of the rectus femoris with retraction of 1.5 cm from the anterior inferior iliac spine. We decided to treat the patient with PRP ultrasound guided injections and a specific rehabilitation protocol.

RESULTS

Clinical evaluation 45 days following the end of the treatment showed the resolution of the pain and the full recovery of strength and range of motion. Muscle healing was documented by magnetic resonance imaging.

CONCLUSIONS

Even if the role of PRP in muscle injury is not still clear, the result observed confirms that it could be used in the treatment of muscle lesions.

Authors+Show Affiliations

PARMA UNIVERSITY DEPARTMENT OF SURGICAL SCIENCES ORTHOPAEDIC AND TRAUMATOLOGY SECTION. fpogliacomi@yahoo.com.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

31821305

Citation

Pogliacomi, Francesco, et al. "Rectus Femoris Myotendinous Lesion Treated With PRP: a Case Report." Acta Bio-medica : Atenei Parmensis, vol. 90, no. 12-S, 2019, pp. 178-183.
Pogliacomi F, Visigalli A, Valenti PG, et al. Rectus femoris myotendinous lesion treated with PRP: a case report. Acta Biomed. 2019;90(12-S):178-183.
Pogliacomi, F., Visigalli, A., Valenti, P. G., Pedrazzini, A., Bernuzzi, G., Concari, G., Vaienti, E., & Ceccarelli, F. (2019). Rectus femoris myotendinous lesion treated with PRP: a case report. Acta Bio-medica : Atenei Parmensis, 90(12-S), 178-183. https://doi.org/10.23750/abm.v90i12-S.8932
Pogliacomi F, et al. Rectus Femoris Myotendinous Lesion Treated With PRP: a Case Report. Acta Biomed. 2019 12 5;90(12-S):178-183. PubMed PMID: 31821305.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Rectus femoris myotendinous lesion treated with PRP: a case report. AU - Pogliacomi,Francesco, AU - Visigalli,Alberto, AU - Valenti,Pier Giulio, AU - Pedrazzini,Alessio, AU - Bernuzzi,Gino, AU - Concari,Giorgio, AU - Vaienti,Enrico, AU - Ceccarelli,Francesco, Y1 - 2019/12/05/ PY - 2019/10/14/received PY - 2019/10/14/accepted PY - 2019/12/11/entrez PY - 2019/12/11/pubmed PY - 2020/11/18/medline SP - 178 EP - 183 JF - Acta bio-medica : Atenei Parmensis JO - Acta Biomed VL - 90 IS - 12-S N2 - BACKGROUND AND AIM OF WORK: Musculoskeletal injuries are the most common cause of severe, chronic pain and physical disability for the majority of all sport-related injuries. Platelet-rich plasma is being used more frequently to promote healing of muscle injuries. We report a case of 39 years old non professional soccer player who came to our attention for a quadriceps muscle pain onset after kicking the ball during a match. METHODS: Clinical and instrumental evaluation revealed a myotendinous junction rupture of the rectus femoris with retraction of 1.5 cm from the anterior inferior iliac spine. We decided to treat the patient with PRP ultrasound guided injections and a specific rehabilitation protocol. RESULTS: Clinical evaluation 45 days following the end of the treatment showed the resolution of the pain and the full recovery of strength and range of motion. Muscle healing was documented by magnetic resonance imaging. CONCLUSIONS: Even if the role of PRP in muscle injury is not still clear, the result observed confirms that it could be used in the treatment of muscle lesions. SN - 2531-6745 UR - https://www.unboundmedicine.com/medline/citation/31821305/ L2 - https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31821305/ DB - PRIME DP - Unbound Medicine ER -